Angiotensin II (Ang II) activates the RhoA/Rho kinase signaling pathway, inhibits myosin light chain phosphatase (MLCP) and endothelial nitric oxide synthase (eNOS) activity, leading to vasoconstriction and endothelial dysfunction (19). The gene discussed is AGT; the disease is endothelial dysfunction.